Article

Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of…

Canadian Journal of Gastroenterology and Hepatology · 2020 · Dawei Jiang, author Xiangfei Yuan, author Jianqi Ni, author Lan Shen, author Min Cai, author Liu Xu, author Antonio Giovanni Solimando, Academic Editor

Key facts

Title Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study
First author Dawei Jiang, author Xiangfei Yuan, author Jianqi Ni, author Lan Shen, author Min Cai, author Liu Xu, author Antonio Giovanni Solimando, Academic Editor
Journal Canadian Journal of Gastroenterology and Hepatology
Published Sep 2, 2020
DOI 10.1155/2021/8882129
Devices mentioned K781043
Product codes mentioned JRL

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature